Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $18,779 | $42,134 | $44,744 |
| - Cash | $4,144 | $10,216 | $10,111 | $3,762 |
| + Debt | $2,968 | $19,388 | $25,669 | $29,709 |
| Enterprise Value | – | $27,951 | $57,692 | $70,691 |
| Revenue | $0 | $0 | $172 | $1,028 |
| % Growth | – | -100% | -83.3% | – |
| Gross Profit | $0 | $0 | $172 | $1,028 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$6,966 | -$10,107 | -$11,544 | -$14,332 |
| % Margin | – | – | -6,711.6% | -1,394.2% |
| Net Income | -$5,412 | -$6,692 | -$7,264 | -$8,947 |
| % Margin | – | – | -4,223.3% | -870.3% |
| EPS Diluted | -0.12 | -0.18 | -0.22 | -0.27 |
| % Growth | 33.3% | 18.2% | 18.5% | – |
| Operating Cash Flow | -$5,063 | -$5,796 | -$8,149 | -$8,655 |
| Capital Expenditures | $0 | -$37 | -$51 | -$31 |
| Free Cash Flow | -$5,063 | -$5,833 | -$8,200 | -$8,686 |